Role of the Insulin-Like Growth Factor I Decline in the Induction of Atrogin-1/MAFbx during Fasting and Diabetes

Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, United States
Endocrinology (Impact Factor: 4.64). 11/2004; 145(11):4806-12. DOI: 10.1210/en.2004-0406
Source: PubMed

ABSTRACT In catabolic conditions, atrogin-1/MAFbx, a muscle-specific ubiquitin-ligase required for muscle atrophy, is increased, and concentrations of IGF-I, a growth factor known to have antiproteolytic action, are reduced. To define the relationship between the decline in IGF-I and the induction of atrogin-1/MAFbx, we studied the effect of IGF-I replacement on atrogin-1/MAFbx mRNA in rats fasted for 51 h and in rats made diabetic with streptozotocin (STZ). Fasting produced a 5.8-fold increase in atrogin-1/MAFbx (P < 0.001). This was attenuated to a 2.5-fold increase by injections of IGF-I (P < 0.05 vs. fasting). Animals with STZ-induced diabetes experienced a 15.1-fold increase in atrogin-1/MAFbx (P < 0.001). Normalization of their circulating IGF-I concentrations by IGF-I infusion blunted the induction of atrogin-1/MAFbx to 6.3-fold (P < 0.05 vs. STZ diabetes without IGF-I). To further delineate the regulation of atrogin-1/MAFbx by IGF-I, we studied a model of cultured muscle cells. We observed that IGF-I produced a time- and dose-dependent reduction of atrogin-1/MAFbx mRNA, with a 50% effective dose of 5 nm IGF-I, a physiological concentration. The degradation rate of atrogin-1/MAFbx mRNA was not affected by IGF-I, suggesting that the reduction of atrogin-1/MAFbx mRNA by IGF-I is a transcriptional effect. Exposure of muscle cells in culture to dexamethasone increased atrogin-1/MAFbx mRNA with a 50% effective dose of 10 nm, a pharmacological concentration. In the presence of dexamethasone, IGF-I at physiological concentrations retained its full inhibitory effect on atrogin-1/MAFbx mRNA. We conclude that IGF-I inhibits atrogin-1/MAFbx expression and speculate that this effect might contribute to the antiproteolytic action of IGF-I in muscle.

Download full-text


Available from: Jean-Paul Thissen, Apr 30, 2014
1 Follower
  • Source
    • "Of particular importance, GH-induced JAK2 signaling activates PI3K and, thereby, the previously mentioned Akt/mTOR protein synthesis pathway [26]. Unlike anabolic signal, the cortisol (in human) and corticosterone (in rats) activate the major protein degradation pathway, the ubiquitin–proteasome system, inhibit IGF-1 production in muscle [27] [28] and enhance the transcription of REED1, resulting in reducd mTOR activity and its targets [29]. The ubiquitin–proteasome system plays an important role for the degradation of longlived myofibrillar proteins in skeletal muscle. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sleep is important for maintenance of skeletal muscle health. Sleep debt can induce muscle atrophy by increasing glucocorticoids and decreasing testosterone, growth hormone and insulin-like growth factor-I. These hormonal alterations result in a highly proteolytic environment characterized by decreased protein synthesis and increased degradation. Given that sleep deprivation is increasingly prevalent in modern society, strategies to minimize or reverse its adverse effects need to be investigated. Resistance exercise has been suggested as an intervention that would benefit the muscle health. The practice of this type of exercise can increase the concentration of testosterone, growth hormone and insulin-like growth factor I and stimulate the protein synthesis through a key signaling molecule, mammalian target of rapamycin. Thus, we hypothesized that resistance exercise is an important non-pharmacological strategy to counteract deleterious effects of sleep debt on skeletal muscle.
    Medical Hypotheses 03/2013; 80(6). DOI:10.1016/j.mehy.2013.02.013 · 1.07 Impact Factor
  • Source
    • "Decreased production of insulin-like growth factor-I (IGF- I) (Cioffi et al. 1994) and increased production of proinflammatory cytokines like interleukin-6, TNF-a and IFN-c have been shown to play roles in muscle atrophy (Shea et al. 2003). Decreased levels of IGF-I are associated with increased muscle wasting and proteolysis through the ubiquitin–proteasome system (Dehoux et al. 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: After severe burn injury, proinflammatory cytokine levels are elevated in serum and skeletal muscle, which in turn increases protein breakdown and decreases protein synthesis. In this study, C2C12 mouse skeletal muscle cell line myotubes were exposed to proinflammatory cytokines tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) as an in vitro cell-line model of catabolic response to burn injury and then treated with des-acyl ghrelin (DAG), a 28 amino acid polypeptide hormone thought to inhibit protein breakdown and increase protein synthesis, to assess its therapeutic potential. Nuclear magnetic resonance-based metabonomics was used to monitor metabolic activity of C2C12 myotubes under four treatment conditions: (1) control, (2) TNF-α/IFN-γ (TI), (3) DAG (DA), and (4) TNF-α/IFN-γ followed by DAG (TIDA) to assess the effect of DAG treatment on cellular metabolic response during basal or catabolic conditions. Twelve metabolites showed significant changes in concentrations following treatments in the hydrophilic cell extracts. Lactate (P<10−4) and citrulline (P<10−9) increased with TNF-α/IFN-γ treatment, indicating increased protein degradation, and returned to control levels in the TIDA group. Adenosine nucleotide levels had decreased trends in TI myotubes that returned to baseline levels after DAG treatment (P<10−4). Guanidinoacetate and pantothenate, metabolites involved in protein synthesis and cell proliferation, had increased concentration trends following DAG treatment in both the DA and TIDA groups. Our metabonomics analysis provides further evidence that DAG counteracts the catabolic response caused by elevated muscle TNF-α/IFN-γ cytokine levels following severe burns and can play a potential therapeutic role in treatment of burn injury. KeywordsNMR–Metabonomics–Metabolic profiling–C2C12 myotubes–Skeletal muscle cell–DAG–Burn injury–Protein breakdown
    International Journal of Peptide Research and Therapeutics 12/2011; 17(4):281-299. DOI:10.1007/s10989-011-9264-x · 0.83 Impact Factor
  • Source
    • "Additionally, the effects of E3 ligases activation was markedly increased in non-treated animals when compared to IGF-1-treated animals. Moreover, the addition of this hormone also inhibited the expression of the ubiquitin-ligase in culture muscle cells incubated with high doses of glucocorticoids (Dehoux et al. 2004). However, again, more studies are needed to determine whether the actions of HMB are direct or mediated by an increased expression of IGF-1. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Amino acids such as leucine and its metabolite α-ketoisocaproate (KIC), are returning to be the focus of studies, mainly because of their anti-catabolic properties, through inhibition of muscle proteolysis and enhancement of protein synthesis. It is clear that these effects may counteract catabolic conditions, as well as enhance skeletal muscle mass and strength in athletes. Moreover, beta-hydroxy-beta-methylbutyrate (HMB) has been shown to produce an important effect in reducing muscle damage induced by mechanical stimuli of skeletal muscle. This review aims to describe the general scientific evidence of KIC and HMB supplementation clinical relevance, as well as their effects (e.g., increases in skeletal muscle mass and/or strength), associated with resistance training or other sports. Moreover, the possible mechanisms of cell signaling regulation leading to increases and/or sparing (during catabolic conditions) of skeletal muscle mass are discussed in detail based on the recent literature.
    Amino Acids 04/2011; 40(4):1015-25. DOI:10.1007/s00726-010-0678-0 · 3.65 Impact Factor
Show more